The Global Health Policy Center leads CSIS’s research bridging foreign policy and public health communities.

War in Gaza

Dahlia Scheindlin on Israeli Opinion—Gaza: The Human Toll

Dahlia Scheindlin, political analyst and columnist for Haaretz and author of The Crooked Timber of Democracy in Israel joined CSIS’s J. Stephen Morrison to discuss the Israeli opinion environment on the health and humanitarian crises in Gaza.

Transcript — August 29, 2024

See all analysis on Global Health

Latest Podcasts

See all podcasts on Global Health
CSIS the truth of the matter

Mpox Outbreak

Podcast Episode by H. Andrew Schwartz and J. Stephen Morrison — August 21, 2024

Past Events

See all events on Global Health

Related Programs

Experts

Katherine E. Bliss

Katherine E. Bliss

Senior Fellow and Director, Immunizations and Health Systems Resilience, Global Health Policy Center
Bhawna Prakash

Bhawna Prakash

Senior Fellow, Water and Sanitation, Chair in U.S.-India Policy Studies
Jon B. Alterman

Zane Swanson

Fellow, Global Food and Water Security Program

All Global Health Content

Filter by

1 - 10 of 476 results

Dahlia Scheindlin on Israeli Opinion—Gaza: The Human Toll

Dahlia Scheindlin, political analyst and columnist for Haaretz and author of The Crooked Timber of Democracy in Israel joined CSIS’s J. Stephen Morrison to discuss the Israeli opinion environment on the health and humanitarian crises in Gaza.

Transcript — August 29, 2024

Gaza's Looming Polio Threat—Gaza: The Human Toll

CSIS welcomed Jean Gough, Special Representative for UNICEF in the State of Palestine; Hamid Jafari, WHO Director of Polio Eradication; and Richard (Rik) Peeperkorn, WHO Representative for Occupied Palestinian Territory, to discuss the threat of polio in Gaza.

Transcript — August 20, 2024

Understanding the U.S. Biopharmaceutical Innovation Ecosystem

While the commercial and national security competition with China has brought policy attention to securing the semiconductor industry, the importance of sustaining a world-leading U.S. biopharmaceutical industry remains underappreciated.

Report by Sujai Shivakumar, Tisyaketu Sirkar, and Jeffrey Depp — August 15, 2024

The Time Is Now for the DOD to Expedite Action on Biosurveillance

After years of struggling to unify its biosurveillance capabilities, the U.S. Department of Defense (DOD) has an opportunity to establish a faster and more comprehensive approach to monitoring biothreats, to better protect U.S. national security and American lives.

Commentary by Thomas Cullison and J. Stephen Morrison — August 15, 2024

Takeaways from the 2024 International AIDS Conference (AIDS 2024)

The CSIS Global Health Policy Center, in partnership with KFF, held a discussion with Rebecca Bunnell, Principal Deputy Coordinator for PEPFAR, reflecting on the major science and policy takeaways from the 25th International AIDS Conference.

Transcript — August 7, 2024

One Year of Over-the-Counter Naloxone

The CSIS Global Health Policy Center discussed the impacts of one year of over-the-counter naloxone with Dr. Rahul Gupta, director of the White House Office of National Drug Control Policy, as well as Paul Williams, senior vice president at Emergent BioSolutions, and Heather Saunders, research manager at KFF.

Transcript — August 1, 2024

Older and Wiser: Defining NATO’s Strategy for Global Aging

In the future, global aging will require NATO to reassess operational readiness, recruitment, and resilience through the deployment of innovative policies that account for shrinking workforces and aging populations at home and new population centers abroad.

Commentary by Eric Palomaa — July 12, 2024